BeOne Medicines AG (HKG:6160)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
176.80
+1.70 (0.97%)
May 29, 2026, 4:08 PM HKT

BeOne Medicines AG Statistics

Total Valuation

HKG:6160 has a market cap or net worth of HKD 250.87 billion. The enterprise value is 222.21 billion.

Market Cap250.87B
Enterprise Value 222.21B

Important Dates

The next estimated earnings date is Monday, August 31, 2026.

Earnings Date Aug 31, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 1.33B
Shares Outstanding n/a
Shares Change (YoY) +10.10%
Shares Change (QoQ) +1.13%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 78.05M

Valuation Ratios

The trailing PE ratio is 59.95 and the forward PE ratio is 40.67.

PE Ratio 59.95
Forward PE 40.67
PS Ratio 5.61
PB Ratio 6.68
P/TBV Ratio 6.94
P/FCF Ratio 27.14
P/OCF Ratio 23.67
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 33.86, with an EV/FCF ratio of 24.04.

EV / Earnings 53.10
EV / Sales 4.97
EV / EBITDA 33.86
EV / EBIT 42.40
EV / FCF 24.04

Financial Position

The company has a current ratio of 3.73, with a Debt / Equity ratio of 0.25.

Current Ratio 3.73
Quick Ratio 3.26
Debt / Equity 0.25
Debt / EBITDA 1.40
Debt / FCF 1.01
Interest Coverage 11.74

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 54.07%
Return on Capital Employed (ROCE) 10.07%
Weighted Average Cost of Capital (WACC) 6.91%
Revenue Per Employee 3.73M
Profits Per Employee 348,708
Employee Count12,000
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, HKG:6160 has paid 973.60 million in taxes.

Income Tax 973.60M
Effective Tax Rate 18.88%

Stock Price Statistics

The stock price has increased by +22.10% in the last 52 weeks. The beta is 0.50, so HKG:6160's price volatility has been lower than the market average.

Beta (5Y) 0.50
52-Week Price Change +22.10%
50-Day Moving Average 180.71
200-Day Moving Average 191.89
Relative Strength Index (RSI) 43.49
Average Volume (20 Days) 4,399,817

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:6160 had revenue of HKD 44.73 billion and earned 4.18 billion in profits. Earnings per share was 35.42.

Revenue44.73B
Gross Profit 39.46B
Operating Income 5.36B
Pretax Income 5.16B
Net Income 4.18B
EBITDA 6.44B
EBIT 5.36B
Earnings Per Share (EPS) 35.42
Full Income Statement

Balance Sheet

The company has 38.00 billion in cash and 9.33 billion in debt, with a net cash position of 28.67 billion.

Cash & Cash Equivalents 38.00B
Total Debt 9.33B
Net Cash 28.67B
Net Cash Per Share n/a
Equity (Book Value) 37.55B
Book Value Per Share 337.90
Working Capital 37.94B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.60 billion and capital expenditures -1.35 billion, giving a free cash flow of 9.24 billion.

Operating Cash Flow 10.60B
Capital Expenditures -1.35B
Depreciation & Amortization 1.10B
Net Borrowing 1.25B
Free Cash Flow 9.24B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 88.23%, with operating and profit margins of 11.98% and 9.36%.

Gross Margin 88.23%
Operating Margin 11.98%
Pretax Margin 11.53%
Profit Margin 9.36%
EBITDA Margin 14.40%
EBIT Margin 11.98%
FCF Margin 20.67%

Dividends & Yields

HKG:6160 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.10%
Shareholder Yield -10.10%
Earnings Yield 1.67%
FCF Yield 3.68%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Analyst Forecast

The average price target for HKG:6160 is 253.18, which is 43.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target 253.18
Price Target Difference 43.19%
Analyst Consensus Strong Buy
Analyst Count 17
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 5